Be Prepared to Dispense More Combo Meds for COPD

February 2026

Patients with COPD will start daily inhalers sooner...as part of the updated COPD guidelines to improve symptoms and decrease mortality.

Still expect patients with acute COPD exacerbation to start with prn short-acting beta agonists (SABAs), such as albuterol...AND short-acting muscarinic antagonists (SAMAs), such as ipratropium.

A SABA/SAMA combo can improve symptoms over either product alone...and may mitigate side effects from higher doses of single agents.

Practical advice for a better career, with unlimited access to CE

Hospital Pharmacy Technician's Letter includes:

12 issues every year, with brief articles about new meds and hot topics
120+ CE courses, including the popular CE-in-the-Letter
Helpful, in-depth Technician Tutorials
Access to the entire archive

Subscribe Today!

Already a subscriber? Log in

Volume pricing available. Get a quote

Medication Errors Spot and Stop Common Errors With GLP-1 Agonists
Allergic Reactions Dig Deeper When Patients Report Antibiotic Allergies
Med Safety Help Leave Room for Safety When Boarding Patients in the ED
Parenteral Nutrition Focus on Safety Limits With Peripheral Parenteral Nutrition
COPD Be Prepared to Dispense More Combo Meds for COPD
Calculations Count On These Tips for Pharmacy Calculations
Immunizations Listen for Questions About Childhood Immunizations
Obesity & Weight Loss Watch for New Rx PO Semaglutide During Transitions of Care

Be Prepared to Dispense More Combo Meds for COPD

Practical advice for a better career, with unlimited access to CE

Table of Contents